OTIPAX, solution ear drops bottle, 16 g
Brand page: Otipax (lidocaine + phenazone) — all forms and strengths in France
Active ingredients: Lidocaine hydrochloride, Antipyrine
Commercialized according to BDPM
Solution for instillationbottle, 16 gauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OTIPAX, solution pour instillation auriculaire
- Pharmaceutical form
- solution pour instillation
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 16 g avec embout(s) avec compte-gouttes polyéthylène acétate de polyvinyle
- Marketing authorisation holder
- BIOCODEX
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1986
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69668703CIP73279066CIP133400932790661Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHÉNAZONEsolution | 4,00 g · 100 g de solution pour instillation auriculaire | SA |
| CHLORHYDRATE DE LIDOCAÏNEsolution | 1,00 g · 100 g de solution pour instillation auriculaire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.